融券方面，华软科技9月30日融券偿还500.00股，融券卖出9400.00股，按当日收盘价计算，卖出金额 6.70万元；融券余量6.49万股，融券余额46.27万元，超过近一年70%分位水平，处于较高位。 资料显示，金陵华软科技股份有限公司位于北京市海淀区东升科技园北街2号院1号楼7层，成立日期 1999年1月13日，上市日期2010年7月20日，公司主营业务涉及计算机软硬件生产、销售。主营业务收入 构成为：AKD系列造纸化学品51.95%，医药、农药中间体17.24%，荧光增白剂16.65%，电子化学品 9.30%，其他4.87%。 9月30日，华软科技跌9.75%，成交额11.85亿元。两融数据显示，当日华软科技获融资买入额9172.27万 元，融资偿还6413.64万元，融资净买入2758.62万元。截至9月30日，华软科技融资融券余额合计2.92亿 元。 截至6月30日，华软科技股东户数4.46万，较上期增加10.26%；人均流通股13743股，较上期减少 9.03%。2025年1月-6月，华软科技实现营业收入1.71亿元，同比减少31.63%；归母净利润-9158.95万 元，同比减少53.21%。 ...

Core Viewpoint - Huasoft Technology (002453) has experienced a significant increase in stock price due to heightened market interest in the "photoresist" concept, despite the company's limited revenue contribution from related products [1][2]. Group 1: Company Overview - Huasoft Technology's main business focuses on the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1]. - The revenue from electronic chemicals is projected to account for less than 6% of the company's total revenue in 2024 [1]. Group 2: Photoresist Business - The company currently produces photo initiator products in small batches based on customer orders, with revenue from these products expected to contribute less than 2% to total revenue in 2024 [1]. - The impact of the photoresist business on the company's overall performance has been minimal for the past two years, and future sales are subject to significant uncertainty due to various influencing factors [1]. Group 3: Market Response - On September 24, Huasoft Technology's stock price rose by 10%, reaching a new high since January 2024, with over 330,000 shares traded at the close [1]. - The company's electronic chemicals business reported revenue of 15.88 million yuan in the first half of 2025, accounting for 9.3% of total revenue, while the 2024 revenue was 30.11 million yuan, representing 5.84% of total revenue [2].

Core Viewpoint - Huasoft Technology (002453) has experienced a significant stock price increase, attributed to heightened market interest in its involvement with the "photoresist" concept, despite the company's limited revenue contribution from this segment [1][2]. Group 1: Company Overview - Huasoft Technology's main business focuses on the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1]. - The electronic chemicals segment is projected to contribute less than 6% to the company's total revenue in 2024 [1]. - The company's existing photoresist products, specifically photoinitiators, are produced in small batches based on customer orders, with revenue from this segment expected to be less than 2% of total revenue in 2024 [1]. Group 2: Market Performance - On September 24, Huasoft Technology's stock price rose by 10%, reaching a new high since January 2024, with over 330,000 shares traded by the end of the day [2]. - As of June 30, 2023, Huasoft Technology had approximately 44,600 shareholders [2]. Group 3: Product Details - Huasoft Technology's electronic chemicals include ML-8, which is a key raw material for coatings used in displays for mobile phones, computers, and televisions, enhancing performance while reducing energy consumption [2]. - The company's electronic chemicals generated revenue of 15.88 million yuan in the first half of 2025, accounting for 9.3% of total revenue, while the projected revenue for 2024 is 30.11 million yuan, representing 5.84% of total revenue [2].

转自：智通财经 【四连板华软科技：现有光引发剂产品按客户订单小批量生产销售 2024年收入占比约不到2%】智通财 经9月24日电，华软科技(002453.SZ)发布股票交易异常波动的公告，公司关注到近期"光刻胶"概念受市 场关注度较高，目前公司主营业务为精细化工产品的研发、生产与销售，主要产品为造纸化学品、医 药/农药中间体、荧光增白剂及电子化学品。其中电子化学品在2024年的营业收入占公司总营收比例不 到6%。关于光刻胶基材业务，公司现有光引发剂产品，按客户订单小批量生产销售，2024年该产品收 入占公司总营收约不到2%，连续两年对公司的经营业绩影响较小，未来销售情况受多种因素影响存在 较大不确定性。 ...

Group 1 - The company, Huasoft Technology (002453.SZ), has announced unusual fluctuations in its stock trading, noting increased market attention on the "photoresist" concept [1] - The company's main business involves the research, production, and sales of fine chemical products, including paper chemicals, pharmaceutical/agricultural intermediates, fluorescent whitening agents, and electronic chemicals [1] - Electronic chemicals are projected to account for less than 6% of the company's total revenue in 2024 [1] Group 2 - Regarding the photoresist substrate business, the company currently produces photoinitiator products in small batches based on customer orders [1] - Revenue from these photoinitiator products is expected to represent about 2% of the company's total revenue in 2024, indicating a minimal impact on the company's operating performance over the past two years [1] - Future sales of these products are subject to significant uncertainty due to various influencing factors [1]

人民财讯9月24日电，华软科技（002453）9月24日发布股票交易异动公告称，公司关注到近期"光刻 胶"概念受市场关注度较高，目前公司主营业务为精细化工产品的研发、生产与销售，主要产品为造纸 化学品、医药/农药中间体、荧光增白剂及电子化学品。其中电子化学品在2024年的营业收入占公司总 营收比例不到6%。关于光刻胶基材业务，公司现有光引发剂产品，按客户订单小批量生产销售，2024 年该产品收入占公司总营收约不到2%，连续两年对公司的经营业绩影响较小，未来销售情况受多种因 素影响存在较大不确定性。 ...

公告显示，公司关注到近期"光刻胶"概念受市场关注度较高，目前公司主营业务为精细化工产品的研 发、生产与销售，主要产品为造纸化学品、医药/农药中间体、荧光增白剂及电子化学品。其中电子化 学品在2024年的营业收入占公司总营收比例不到6%。关于光刻胶基材业务，公司现有光引发剂产品， 按客户订单小批量生产销售，2024年该产品收入占公司总营收约不到2%，连续两年对公司的经营业绩 影响较小，未来销售情况受多种因素影响存在较大不确定性。 智通财经APP讯，华软科技(002453.SZ)公告，公司股票交易价格于2025年9月23日、9月24日连续二个交 易日收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动的情况。 ...

公告显示，公司关注到近期"光刻胶"概念受市场关注度较高，目前公司主营业务为精细化工产品的研 发、生产与销售，主要产品为造纸化学品、医药/农药中间体、荧光增白剂及电子化学品。其中电子化 学品在2024年的营业收入占公司总营收比例不到6%。关于光刻胶基材业务，公司现有光引发剂产品， 按客户订单小批量生产销售，2024年该产品收入占公司总营收约不到2%，连续两年对公司的经营业绩 影响较小，未来销售情况受多种因素影响存在较大不确定性。 智通财经APP讯，华软科技(002453.SZ)公告，公司股票交易价格于2025年9月23日、9月24日连续二个交 易日收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动的情况。 ...

格隆汇9月24日丨华软科技(002453.SZ)公布股票交易异常波动公告，公司关注到近期"光刻胶"概念受市 场关注度较高，目前公司主营业务为精细化工产品的研发、生产与销售，主要产品为造纸化学品、医 药/农药中间体、荧光增白剂及电子化学品。其中电子化学品在2024年的营业收入占公司总营收比例不 到6%。关于光刻胶基材业务，公司现有光引发剂产品，按客户订单小批量生产销售，2024年该产品收 入占公司总营收约不到2%，连续两年对公司的经营业绩影响较小，未来销售情况受多种因素影响存在 较大不确定性。敬请广大投资者注意投资风险，理性投资。 ...

华软科技公告，公司关注到近期"光刻胶"概念受市场关注度较高，目前公司主营业务为精细化工产品的 研发、生产与销售，主要产品为造纸化学品、医药/农药中间体、荧光增白剂及电子化学品。其中电子 化学品在2024年的营业收入占公司总营收比例不到6%。关于光刻胶基材业务，公司现有光引发剂产 品，按客户订单小批量生产销售，2024年该产品收入占公司总营收约不到2%，连续两年对公司的经营 业绩影响较小，未来销售情况受多种因素影响存在较大不确定性。敬请广大投资者注意投资风险，理性 投资。 ...